These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 30572156)
1. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment. Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156 [TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
3. A dual-functional HER2 aptamer-conjugated, pH-activated mesoporous silica nanocarrier-based drug delivery system provides in vitro synergistic cytotoxicity in HER2-positive breast cancer cells. Shen Y; Li M; Liu T; Liu J; Xie Y; Zhang J; Xu S; Liu H Int J Nanomedicine; 2019; 14():4029-4044. PubMed ID: 31213813 [No Abstract] [Full Text] [Related]
4. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles. Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086 [TBL] [Abstract][Full Text] [Related]
5. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery. Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830 [TBL] [Abstract][Full Text] [Related]
6. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation. Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639 [TBL] [Abstract][Full Text] [Related]
7. In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice. Ding Z; Wang D; Shi W; Yang X; Duan S; Mo F; Hou X; Liu A; Lu X Int J Nanomedicine; 2020; 15():8383-8400. PubMed ID: 33149582 [TBL] [Abstract][Full Text] [Related]
8. Multistage pH-responsive mesoporous silica nanohybrids with charge reversal and intracellular release for efficient anticancer drug delivery. Yuan X; Peng S; Lin W; Wang J; Zhang L J Colloid Interface Sci; 2019 Nov; 555():82-93. PubMed ID: 31377647 [TBL] [Abstract][Full Text] [Related]
9. EpCAM aptamer-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery. Xie X; Li F; Zhang H; Lu Y; Lian S; Lin H; Gao Y; Jia L Eur J Pharm Sci; 2016 Feb; 83():28-35. PubMed ID: 26690044 [TBL] [Abstract][Full Text] [Related]
10. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy. Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494 [TBL] [Abstract][Full Text] [Related]
11. Redox-responsive mesoporous selenium delivery of doxorubicin targets MCF-7 cells and synergistically enhances its anti-tumor activity. Zhao S; Yu Q; Pan J; Zhou Y; Cao C; Ouyang JM; Liu J Acta Biomater; 2017 May; 54():294-306. PubMed ID: 28267598 [TBL] [Abstract][Full Text] [Related]
12. Targeted delivery and controlled release of doxorubicin to cancer cells by smart ATP-responsive Y-shaped DNA structure-capped mesoporous silica nanoparticles. Bagheri E; Alibolandi M; Abnous K; Taghdisi SM; Ramezani M J Mater Chem B; 2021 Feb; 9(5):1351-1363. PubMed ID: 33447840 [TBL] [Abstract][Full Text] [Related]
13. Hybrid silica-coated Gd-Zn-Cu-In-S/ZnS bimodal quantum dots as an epithelial cell adhesion molecule targeted drug delivery and imaging system. Akbarzadeh M; Babaei M; Abnous K; Taghdisi SM; Peivandi MT; Ramezani M; Alibolandi M Int J Pharm; 2019 Oct; 570():118645. PubMed ID: 31465835 [TBL] [Abstract][Full Text] [Related]
14. Construction of calcium carbonate-liposome dual-film coated mesoporous silica as a delayed drug release system for antitumor therapy. Wang Y; Zhao K; Xie L; Li K; Zhang W; Xi Z; Wang X; Xia M; Xu L Colloids Surf B Biointerfaces; 2022 Apr; 212():112357. PubMed ID: 35101825 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-Bound Hydroxyethyl Starch Conjugate Nanoparticles with pH/Redox Responsive Linkage for Enhancing Antitumor Therapy. Tan R; Tian D; Liu J; Wang C; Wan Y Int J Nanomedicine; 2021; 16():4527-4544. PubMed ID: 34276212 [TBL] [Abstract][Full Text] [Related]
16. A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy. Zhang J; Shen B; Chen L; Chen L; Meng Y; Feng J Colloids Surf B Biointerfaces; 2019 Mar; 175():65-72. PubMed ID: 30522009 [TBL] [Abstract][Full Text] [Related]
17. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin. Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801 [TBL] [Abstract][Full Text] [Related]
18. Poly(amino acid)/ZnO/mesoporous silica nanoparticle based complex drug delivery system with a charge-reversal property for cancer therapy. Kuang Y; Chen H; Chen Z; Wan L; Liu J; Xu Z; Chen X; Jiang B; Li C Colloids Surf B Biointerfaces; 2019 Sep; 181():461-469. PubMed ID: 31176118 [TBL] [Abstract][Full Text] [Related]
19. Albumin-MnO Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612 [TBL] [Abstract][Full Text] [Related]
20. Disease-directed design of biodegradable polymers: Reactive oxygen species and pH-responsive micellar nanoparticles for anticancer drug delivery. Leong J; Chin W; Ke X; Gao S; Kong H; Hedrick JL; Yang YY Nanomedicine; 2018 Nov; 14(8):2666-2677. PubMed ID: 30017961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]